SLC38A5 and neoplasm: Expression levels of SLC38A5, EMT markers, and ferroptosis markers were reduced in the tumor and livers of the knockdown group in accordance with the in vitro results; the treatment of Ferrostatin-1, however, negated the effect of the knockdown (Figure 6C).